Your browser doesn't support javascript.
loading
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Winchester, Danyelle A; Till, Cathee; Goodman, Phyllis J; Tangen, Catherine M; Santella, Regina M; Johnson-Pais, Teresa L; Leach, Robin J; Xu, Jianfeng; Zheng, S Lilly; Thompson, Ian M; Lucia, M Scott; Lippman, Scott M; Parnes, Howard L; Isaacs, William B; De Marzo, Angelo M; Drake, Charles G; Platz, Elizabeth A.
Afiliación
  • Winchester DA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Till C; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Goodman PJ; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Tangen CM; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Santella RM; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York.
  • Johnson-Pais TL; Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Leach RJ; Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Xu J; Program for Personalized Cancer Care and Department of Surgery, NorthShore University Health System, Evanston, Illinois.
  • Zheng SL; Program for Personalized Cancer Care and Department of Surgery, NorthShore University Health System, Evanston, Illinois.
  • Thompson IM; Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Lucia MS; Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Lippman SM; Department of Pathology, University of Colorado Denver School of Medicine, Aurora, Colorado.
  • Parnes HL; Moores Cancer Center, University of California San Diego, La Jolla, California.
  • Isaacs WB; Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • De Marzo AM; James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Drake CG; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
  • Platz EA; James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Prostate ; 77(8): 908-919, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28317149
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Interleucina-8 / Interleucina-10 / Finasterida / Inflamación Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Interleucina-8 / Interleucina-10 / Finasterida / Inflamación Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Año: 2017 Tipo del documento: Article